Conversely, in mice bearing a tumor under-expressing TF the interaction of cancer cell-derived MPs expressing TFPI with fibrinogen and platelets (via integrin αvβ1 and αvβ3) was associated with decreased bleeding times and shown to hamper activation of the coagulation cascade, platelet aggregation and thrombus formation [244]. The gene discussed is TFPI; the disease is neoplasm.